Author:
Schewe Carl Knud,Maserati Renato,Wassmer Gernot,Adam Axel,Weitner Lutwin
Publisher
Oxford University Press (OUP)
Subject
Infectious Diseases,Microbiology (medical)
Reference9 articles.
1. Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial. 903 Study Group;Gallant;JAMA,2004
2. Evolution of lipid abnormalities in patients switched from stavudine- to tenofovir-containing regimens;Lafeuillade;J Acquir Immune Defic Sydr,2003
3. Evaluation of efficacy and safety of tenofovir DF (TDF) after switch from stavudine (d4T) in 93 chronically HIV-1 infected patients [poster 9.8/2];Schewe,2003
4. Improvement of dyslipidemia in patients switching from stavudine to tenofovir: preliminary results. Recover Study Group;Domingo;AIDS,2004
5. Improvement in lipoatrophy and lipid abnormalities following switch from stavudine (d4T) to tenofovir DF (TDF) in combination with lamivudine (3TC) and efavirenz (EFV) in HIV-infected patients: a 48-week follow-up from Study 903E [poster TuPe2.2B12];Madruga,2005
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献